aod9604 recommended dosage December 4, 2024 Pharmacy Compounding Advisory Committee (PCAC) Meeting aod9604 dosage guidelines aod9604 dosage
Description
Safety Across Different Populations The clinical trial program predominantly enrolled individuals with clinical obesity, providing safety data specifically in this population
Rotate injection sites systematically, moving at least 1 inch from previous injection points
For a 5mg vial, adding 2ml of bacteriostatic water creates a concentration of 2.5mg/ml (2500mcg/ml)
Endocrinology, 142(12), 5182-5189
Most practitioners recommend starting at 250-300 mcg daily to assess tolerance, then potentially increasing to 400-500 mcg if initial response is suboptimal and no side effects occur
